Dasatinib and PD-L1 inhibitors provoke toxicity and inhibit angiogenesis in the embryo
Dasatinib is a targeted cancer therapy, while programmed death ligand 1 (PD-L1) inhibitors are a form of immune checkpoint therapy used to treat various types of cancers. Several studies showed the potential efficacy of these drugs in the management of triple-negative breast cancer- an aggressive su...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , , , , |
| Format: | article |
| Published: |
2020
|
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1016/j.biopha.2020.111134 https://www.sciencedirect.com/science/article/pii/S0753332220313275 http://hdl.handle.net/10576/17228 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|